[1]
2021. The efficacy and safety of two schemes of desensitization to trimethoprim-sulfamethoxazole in HIV-positive patients. Revista Alergia México. 67, 3 (Jan. 2021), 237–244. DOI:https://doi.org/10.29262/ram.v67i3.745.